NCT01696734View on ClinicalTrials.gov

Domperidone in Treating Patients With Gastrointestinal Disorders

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 23, 2012

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Digestive System DisorderDyspepsiaEsophagitisGastroesophageal Reflux DiseaseGastroparesisHeartburnNausea and Vomiting
Interventions
DRUG

Domperidone

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER